Screener
AngioDynamics ANGO Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by AngioDynamics in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesCurrent.
The source filing: AngioDynamics’s 10-K, filed July 14, 2026.
- Filed
- Jul 14, 2026, 3:42 PM EDT
- Fiscal year
- FY2026
- Accession
- 0001628280-26-048138
| Line item | May 31, 2026 | May 31, 2025 |
|---|---|---|
| Current Liabilities | ||
| Accounts payable | $31,513 | $33,291 |
| Accrued liabilities | 38,909 | 35,518 |
| Other current liabilities | 4,295 | 7,388 |
| Total current liabilities | 74,717 | 76,197 |
| Deferred income taxes | 5,316 | 4,073 |
| Other long-term liabilities | 16,305 | 16,904 |
| Total Liabilities | 96,338 | 97,174 |
Item 15. Exhibits, Financial Statement Schedules.
FAQ
- What is AngioDynamics's accrued expenses?
- AngioDynamics (ANGO) reported accrued expenses of $4.3M in Q1 2026.
- How has AngioDynamics's accrued expenses changed year-over-year?
- AngioDynamics's accrued expenses decreased by 41.9% year-over-year, from $7.39M to $4.3M.
- What is the long-term trend for AngioDynamics's accrued expenses?
- Over 5 years (2021 to 2026), AngioDynamics's accrued expenses has grown at a 11.5% compound annual growth rate (CAGR), from $2.5M to $4.3M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.
Ask your AI about AngioDynamics's accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude